Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,063,811

« Back to Dashboard
Patent 6,063,811 protects VIOXX and is included in two NDAs.

Protection for VIOXX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-seven patent family members in thirty-one countries.

Summary for Patent: 6,063,811

Title: Compositions for a once day treatment of cyclooxygenase-2 mediated diseases
Abstract:This application relates to a method of treating a disease susceptible to treatment with a non-steroidal anti-inflammatory drug by administering to a patient once daily an effective amount of 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone.
Inventor(s): Hancock; Bruno (Beaconsfield, CA), Winters; Conrad (L'Ile Bizard, CA), Gertz; Barry (Summit, NJ), Ehrich; Elliot (Chatham, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ) Merch Frosst Canada & Co. (Kirkland, CA)
Application Number:09/180,647
Patent Claim Types:
see list of patent claims
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 3rd percentile
Forward Citations: 2nd percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
TABLET;ORAL021042-001May 20, 1999DISCNNo6,063,811*PED► subscribeY
TABLET;ORAL021042-002May 20, 1999DISCNNo6,063,811*PED► subscribeY
TABLET;ORAL021042-003Feb 25, 2000DISCNNo6,063,811*PED► subscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,063,811

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9612063Jun 10, 1996
PCT Information
PCT FiledMay 13, 1997PCT Application Number:PCT/US97/08041
PCT Publication Date:November 27, 1997PCT Publication Number: WO97/44028

International Patent Family for Patent: 6,063,811

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina012014► subscribe
Australia3004997► subscribe
Bulgaria103000► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.